Appointment of Mr. Subrata Samanta as a Chief Financial officer of the company with effect from 07.10.2026.

Date: 07-10-2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001 Scrip Code: 526075 Subject: Announcement regarding Appointment of Chief Financial Officer Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Rekvina Laboratories Limited (“the Company”), at its meeting held on 07th October, 2026, has approved the appointment of Mr. Subrata Samanta as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from 07th October, 2026. Mr. Subrata Samanta has confirmed that he is not debarred from holding the office of Chief Financial Officer by virtue of any order of SEBI or any other statutory authority. The Board Meeting commenced at 06:50 p.m. and concluded at 7:15 p.m. You are requested to kindly take the above information on record. Thanking you, For Rekvina Laboratories Limited Surbhit Mukesh Shah Director DIN: 01993300 CIN: L24231GJ1988PLC01145 Regd. Office: 3rd floor 5 Laxmi Society, B/h Baroda Heart Institute, O.P. Road, Vadodara – 390007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966 The requisite details pursuant to Regulation 30 of the SEBI Listing Regulations are as follows: Particulars Details Name Mr. Subrata Samanta Designation Chief Financial Officer (CFO) & Key Managerial Personnel Date of Appointment 07-10-26 Reason for Appointment Appointment of Chief Financial Officer Subrata Samanta is a seasoned Finance and Costing professional with 20+ years of experience in Accounting, Finance, Costing, Budgeting, MIS, Taxation, Cost Audit and Financial Planning. He has worked with reputed multinational and Indian organizations including GNFC, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Intas Pharmaceuticals, RPG Life Sciences, Valmont Industries, Hindustan Lever and PricewaterhouseCoopers. He has extensive experience in SAP FICO, product costing, cost accounting, budgeting, financial reporting, cash-flow management, cost audit, due diligence, MIS and statutory compliances. He has also played key roles in SAP implementations, acquisition and integration of manufacturing Profile facilities, activity-based costing, R&D costing and development of costing and accounting systems. He has served in senior finance roles, including Chief Manager (Finance) at Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC), with responsibility for accounting operations, budgeting, costing, financial analysis, treasury, cost audit, taxation, banking, compliance and management reporting. He holds an M.Com. from Calcutta University and is an Associate Cost and Management Accountant (ACMA). His strong combination of financial, costing, ERP and management experience enables him to contribute effectively to strategic financial management and operational cost optimisation. Disclosure of relationship between Directors Not Applicable Information as required under circular No. LIST/COMP/14/ 2018-19 and NSE/CML/2018/ 24 dated June 20, 2018 issued by BSE and NSE respectively Not Applicable CIN: L24231GJ1988PLC01145 Regd. Office: 3rd floor 5 Laxmi Society, B/h Baroda Heart Institute, O.P. Road, Vadodara – 390007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966